advertisement

Alma Lasers launches nationwide radiation tattoo removal program

PRNewswire

BUFFALO GROVE — Alma Lasers, a global developer, manufacturer and provider of laser, light-based, radio-frequency and ultrasound devices for aesthetic and medical applications, said it will launch a nationwide free radiation tattoo removal program in honor of National Breast Cancer Awareness Month.

The Declare Your Freedom program is open to qualifying breast cancer survivors during the month of October.

Radiation therapists routinely mark patients with tattoos in order to accurately target the treatment area. If you are a breast cancer survivor whose course of treatment has been successfully completed, and if your oncologist approves of your decision to have your therapy tattoos removed, Alma Lasers will help you find a local qualified provider offering laser tattoo removal, free, for a limited time.

“What better way to express our admiration for breast cancer survivors than to provide resources within the community to allow survivors to declare their freedom,” said Ziv Karni, president and CEO.  “For the second year, we chose to support the many strong and brave women who have battled breast cancer as we enjoy being part of the solution.”

Participating Declare Your Freedom providers use the Alma Lasers Harmony cosmetic laser system with the Q-Switched Nd:YAG laser, the most reliable and frequently used laser for effective laser tattoo removal.

“Alma Lasers is proud to support breast cancer survivors during National Breast Cancer Awareness Month as this deadly disease affects so many of us either directly or indirectly,” said Avi Farbstein, general manager of North American Operations.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.